LFMD LifeMD Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LFMD

Price (delayed)

$12.51

Market cap

$504.98M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.7

Enterprise value

$490.76M

LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordable ...

Highlights
LifeMD's equity has surged by 131% YoY and by 128% QoQ
The quick ratio has soared by 80% from the previous quarter
Sector: Healthcare
Industry: Pharmaceutical Retailers
Website: http://lifemd.com
Peers: PGY PHR PHUN

Key stats

What are the main financial stats of LFMD
Market
Shares outstanding
40.37M
Market cap
$504.98M
Enterprise value
$490.76M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
135.54
Price to sales (P/S)
2.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.22
Earnings
Revenue
$152.55M
EBIT
-$17.57M
EBITDA
-$10.97M
Free cash flow
$235,816
Per share
EPS
-$0.7
Free cash flow per share
$0.01
Book value per share
$0.09
Revenue per share
$4.5
TBVPS
$1.29
Balance sheet
Total assets
$58.48M
Total liabilities
$52.91M
Debt
$18.93M
Equity
$3.51M
Working capital
$7.82M
Liquidity
Debt to equity
5.4
Current ratio
1.22
Quick ratio
1.1
Net debt/EBITDA
1.3
Margins
EBITDA margin
-7.2%
Gross margin
87.6%
Net margin
-13.5%
Operating margin
-9.5%
Efficiency
Return on assets
-56.3%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-74.1%
Return on sales
-11.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LFMD stock price

How has the LifeMD stock price performed over time
Intraday
0.16%
1 week
4.69%
1 month
23.49%
1 year
714.98%
YTD
50.9%
QTD
21.69%

Financial performance

How have LifeMD's revenue and profit performed over time
Revenue
$152.55M
Gross profit
$133.65M
Operating income
-$14.49M
Net income
-$20.6M
Gross margin
87.6%
Net margin
-13.5%
LFMD's operating margin has soared by 77% year-on-year and by 49% since the previous quarter
LFMD's operating income has soared by 70% YoY and by 43% from the previous quarter
The net margin has surged by 65% year-on-year and by 36% since the previous quarter
LifeMD's net income has surged by 55% YoY and by 28% QoQ

Growth

What is LifeMD's growth rate over time

Valuation

What is LifeMD stock price valuation
P/E
N/A
P/B
135.54
P/S
2.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.22
The EPS has soared by 55% YoY and by 29% from the previous quarter
LifeMD's equity has surged by 131% YoY and by 128% QoQ
The P/S is 132% above the last 4 quarters average of 1.2 and 54% above the 5-year quarterly average of 1.8
The revenue has grown by 28% YoY and by 12% from the previous quarter

Efficiency

How efficient is LifeMD business performance
The ROS has soared by 69% YoY and by 39% from the previous quarter
LFMD's ROA has soared by 57% year-on-year and by 40% since the previous quarter

Dividends

What is LFMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFMD.

Financial health

How did LifeMD financials performed over time
LifeMD's total assets is 11% more than its total liabilities
LifeMD's total assets has soared by 128% YoY and by 44% from the previous quarter
The quick ratio has soared by 80% from the previous quarter
LifeMD's equity has surged by 131% YoY and by 128% QoQ
The debt has declined by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.